Advanced glycation end products and their receptor contribute to ovarian ageing

Human Reproduction

Volumn 29, Issue 1, 2014, Pages 125-134

  Stensen, Mette Haug ^a   Tanbo, Tom ^a,b   Storeng, Ritsa ^a   Fedorcsak, Peter ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Advanced glycation end products; Assisted reproduction; Cell culture; Cell signalling; Female infertility

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; CASPASE 3; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5;

AGE; AGING; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; FOLLICLE FLUID; GRANULOSA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INFERTILITY THERAPY; MONOCYTE; OVARY; OVARY FOLLICLE; OVARY FOLLICLE FLUID; PROTEIN BINDING; THECA CELL;

BOVINAE;

ADVANCED GLYCATION END PRODUCTS; ASSISTED REPRODUCTION; CELL CULTURE; CELL SIGNALLING; FEMALE INFERTILITY;

FEMALE; FOLLICULAR FLUID; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; OVARY; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN, BOVINE;

EID: 84890646558     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det419     Document Type: Article

References (45)

1. Basta G, Schmidt AM, De CR. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004;63:582-592.
2. Bhatwadekar AD, Ghole VS. Rapid method for the preparation of an AGE-BSA standard calibrator using thermal glycation. J Clin Lab Anal 2005; 19:11-15.
3. Bonetti TC, Borges E Jr, Braga DP, Iaconelli A Jr, Kleine JP, Silva ID. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction. Reprod Biomed Online 2013;26:62-67.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
5. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101:527-537.
6. Bukulmez O, Arici A. Leukocytes in ovarian function. Hum Reprod Update 2000;6:1-15.
7. ByskovAG. Differentiation of mammalian embryonic gonad. Physiol Rev 1986; 66:71-117.
8. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 1997; 94:13915-13920.
9. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, Patsouris E, Papavassiliou AG. Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl) 2007a;85:1413-1420.
10. Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, Duleba AJ. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 2007b;127:581-589.
11. Espey LL. Ovulation as an inflammatory reaction-a hypothesis. Biol Reprod 1980;22:73-106.
12. Faddy MJ, Gosden RG. Amodel conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 1996;11:1484-1486.
13. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342-1346.
14. Fedorcsak P, Raki M, Storeng R. Characterization and depletion of leukocytes from cells isolated from the pre-ovulatory ovarian follicle. Hum Reprod 2007;22:989-994.
15. Fedorcsak P, Polec A, Raki M, Holm R, Jebsen P, Abyholm T. Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes. Endocrinology 2010;151:1290-1298.
16. Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil Steril 2010;94:694-700.
17. Fujisawa K, Katakami N, Kaneto H, Naka T, Takahara M, Sakamoto F, Irie Y, Miyashita K, Kubo F, Yasuda T et al. Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes. Atherosclerosis 2013;227:425-428.
18. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605.
19. Hofmann MA, Drury S, Fu C, QuW, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P et al. RAGEmediates a novel proinflammatoryaxis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
20. Kirkwood TB. A systematic look at an old problem. Nature 2008; 451:644-647.
21. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87:9010-9014.
22. Konishi H, Nakatsuka M, Chekir C, Noguchi S, Kamada Y, Sasaki A, Hiramatsu Y. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod 2004;19:2156-2162.
23. Krajcovicova-Kudlackova M, Sebekova K, Schinzel R, Klvanova J. Advanced glycation end products and nutrition. Physiol Res 2002;51:313-316.
24. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997;272:17810-17814.
25. Li J, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997; 272:16498-16506.
26. Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients 2010;2:1247-1265.
27. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP. The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 1999;10:157-167.
28. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267:14998-15004.
29. Neumann A, Schinzel R, PalmD, Riederer P, Munch G. Highmolecularweight hyaluronic acid inhibits advanced glycation endproduct-inducedNF-kappaB activation and cytokine expression. FEBS Lett 1999;453:283-287.
30. Opoien HK, Fedorcsak P, Polec A, Stensen MH, Abyholm T, Tanbo T. Do endometriomas induce an inflammatory reaction in nearby follicles? Hum Reprod 2013;28:1837-1845.
31. Polec A, Raki M, Abyholm T, Tanbo TG, Fedorcsak P. Interaction between granulosa-lutein cells and monocytes regulates secretion of angiogenic factors in vitro. Hum Reprod 2011;26:2819-2829.
32. Rodgers RJ, Irving-Rodgers HF, Russell DL. Extracellular matrix of the developing ovarian follicle. Reproduction 2003;126:415-424.
33. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 1993;91:2155-2168.
34. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000;1498:99-111.
35. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-955.
36. Selvin E, Halushka M, Rawlings A, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC. sRAGE and risk of diabetes, cardiovascular disease and death. Diabetes 2013;62:2116-2121.
37. Smith MP, Flannery GR, Randle BJ, Jenkins JM, Holmes CH. Leukocyte origin and profile in follicular aspirates at oocyte retrieval. Hum Reprod 2005; 20:3526-3531.
38. Stensen MH, Tanbo T, Storeng R, Byholm T, Fedorcsak P. Routine morphological scoring systems in assisted reproduction treatment fail to reflect age-related impairment of oocyte and embryo quality. Reprod Biomed Online 2010;21:118-125.
39. Tamura Y, Adachi H, Osuga J, Ohashi K, Yahagi N, Sekiya M, Okazaki H, Tomita S, Iizuka Y, Shimano H et al. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J Biol Chem 2003; 278:12613-12617.
40. Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, Artini PG, Piomboni P, Focarelli R. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 2008;14:131-142.
41. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
42. Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 1996;9:69-77.
43. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994; 91:4766-4770.
44. Xu D, Kyriakis JM. Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J Biol Chem 2003;278:39349-39355.
45. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584-592.